13 November 2017 - PARIS--(BUSINESS WIRE)--Regulatory News:
CARMAT, the designer and developer of the world’s most advanced artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announces that it has signed a partnership agreement with AddUp, the Joint Venture specialized in 3D printing set up by the Michelin and Fives groups.
The aim of this collaboration is to strengthen the industrial development of the CARMAT heart and contribute to increase the Company’s production capacity in preparation for the large scale production phase.
Photo: CARMAT's Artificial Heart project (credit: Carmat)
Thanks to AddUp’s expertise, CARMAT will ultimately be able to provide surgeons and patients with a version of its artificial heart that incorporates all the technological benefits of 3D printing, and in particular:
- optimized anatomical interfaces leading to enhanced anatomical compatibility and surgical comfort;
- reduction in the number of components, thus better securing the device’s assembly.